Efficacy and safety of Huashi Baidu granule plus Nirmatrelvir-Ritonavir combination therapy in patients with high-risk factors infected with Omicron (B.1.1.529): A multi-arm single-center, open-label, randomized controlled trial

{ 'indexed': {'date-parts': [[2023, 8, 27]], 'date-time': '2023-08-27T14:11:10Z', 'timestamp': 1693145470222}, 'reference-count': 27, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2023, 11, 1]], 'date-time': '2023-11-01T00:00:00Z', 'timestamp': 1698796800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2023, 11, 1]], 'date-time': '2023-11-01T00:00:00Z', 'timestamp': 1698796800000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-017'}, { 'start': { 'date-parts': [[2023, 11, 1]], 'date-time': '2023-11-01T00:00:00Z', 'timestamp': 1698796800000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-037'}, { 'start': { 'date-parts': [[2023, 11, 1]], 'date-time': '2023-11-01T00:00:00Z', 'timestamp': 1698796800000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-012'}, { 'start': { 'date-parts': [[2023, 11, 1]], 'date-time': '2023-11-01T00:00:00Z', 'timestamp': 1698796800000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-029'}, { 'start': { 'date-parts': [[2023, 11, 1]], 'date-time': '2023-11-01T00:00:00Z', 'timestamp': 1698796800000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-004'}], 'content-domain': {'domain': ['elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2023, 11]]}, 'DOI': '10.1016/j.phymed.2023.155025', 'type': 'journal-article', 'created': {'date-parts': [[2023, 8, 16]], 'date-time': '2023-08-16T15:39:30Z', 'timestamp': 1692200370000}, 'page': '155025', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Efficacy and safety of Huashi Baidu granule plus Nirmatrelvir-Ritonavir combination therapy in ' 'patients with high-risk factors infected with Omicron (B.1.1.529): A multi-arm single-center, ' 'open-label, randomized controlled trial', 'prefix': '10.1016', 'volume': '120', 'author': [ { 'ORCID': 'http://orcid.org/0000-0003-4100-8415', 'authenticated-orcid': False, 'given': 'Zhuo', 'family': 'Yu', 'sequence': 'first', 'affiliation': []}, {'given': 'Yanxi', 'family': 'Zheng', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bowu', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jia', 'family': 'Lv', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiaojun', 'family': 'Zhu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Binyi', 'family': 'Shang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yuping', 'family': 'Xv', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ru', 'family': 'Tao', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yanbing', 'family': 'Yang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jun', 'family': 'Cong', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dan', 'family': 'Li', 'sequence': 'additional', 'affiliation': []}, {'given': 'Huan', 'family': 'Wu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Wenchao', 'family': 'Qv', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiyi', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chengbin', 'family': 'Xv', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-9820-7111', 'authenticated-orcid': False, 'given': 'Hai', 'family': 'Feng', 'sequence': 'additional', 'affiliation': []}, {'given': 'Weian', 'family': 'Yuan', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-7276-9810', 'authenticated-orcid': False, 'given': 'Yueqiu', 'family': 'Gao', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.phymed.2023.155025_bib0001', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fmed.2022.849217', 'article-title': 'The biological functions and clinical significance of SARS-CoV-2 ' 'variants of corcern', 'volume': '9', 'author': 'Akkiz', 'year': '2022', 'journal-title': 'Front. Med.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0002', 'series-title': 'StatPearls', 'article-title': 'Emerging variants of SARS-CoV-2 and novel therapeutics against ' 'coronavirus (COVID-19), updated 2022 May 12 ed', 'author': 'Aleem', 'year': '2022'}, { 'key': '10.1016/j.phymed.2023.155025_bib0003', 'doi-asserted-by': 'crossref', 'first-page': '1763', 'DOI': '10.1126/science.1085658', 'article-title': 'Coronavirus main proteinase (3CLpro) structure: basis for design of ' 'anti-SARS drugs', 'volume': '300', 'author': 'Anand', 'year': '2003', 'journal-title': 'Science'}, { 'key': '10.1016/j.phymed.2023.155025_bib0004', 'doi-asserted-by': 'crossref', 'first-page': '3864', 'DOI': '10.21037/apm-20-1759', 'article-title': 'The pharmacological mechanism of Huashi Baidu Formula for the treatment ' 'of COVID-19 by combined network pharmacology and molecular docking', 'volume': '10', 'author': 'Cai', 'year': '2021', 'journal-title': 'Ann. Palliat Med.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0005', 'doi-asserted-by': 'crossref', 'first-page': '452', 'DOI': '10.1136/bmj.310.6977.452', 'article-title': 'The number needed to treat: a clinically useful measure of treatment ' 'effect', 'volume': '310', 'author': 'Cook', 'year': '1995', 'journal-title': 'BMJ'}, { 'key': '10.1016/j.phymed.2023.155025_bib0006', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.drup.2021.100794', 'article-title': 'An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) ' 'treatment', 'volume': '59', 'author': 'Drozdzal', 'year': '2021', 'journal-title': 'Drug Resist. Updat.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0007', 'doi-asserted-by': 'crossref', 'first-page': 'o1037', 'DOI': '10.1136/bmj.o1037', 'article-title': 'COVID-19: what is the evidence for the antiviral Paxlovid?', 'volume': '377', 'author': 'Extance', 'year': '2022', 'journal-title': 'BMJ'}, { 'key': '10.1016/j.phymed.2023.155025_bib0008', 'doi-asserted-by': 'crossref', 'first-page': '88', 'DOI': '10.1016/j.bbrc.2020.10.102', 'article-title': 'Evolution patterns of SARS-CoV-2: snapshot on its genome variants', 'volume': '538', 'author': 'Giovanetti', 'year': '2021', 'journal-title': 'Biochem. Biophys. Res. Commun.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0009', 'doi-asserted-by': 'crossref', 'first-page': '693', 'DOI': '10.1056/NEJMoa2021436', 'article-title': 'Dexamethasone in hospitalized patients with COVID-19', 'volume': '384', 'author': 'Horby', 'year': '2021', 'journal-title': 'N. Engl. J. Med.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0010', 'doi-asserted-by': 'crossref', 'first-page': '1330', 'DOI': '10.1001/jama.2020.17023', 'article-title': 'Association between administration of systemic corticosteroids and ' 'mortality among critically ill patients with COVID-19: a meta-analysis', 'volume': '324', 'author': 'Sterne', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.phymed.2023.155025_bib0011', 'doi-asserted-by': 'crossref', 'first-page': '1397', 'DOI': '10.1056/NEJMoa2118542', 'article-title': 'Oral Nirmatrelvir for high-risk, nonhospitalized adults with COVID-19', 'volume': '386', 'author': 'Hammond', 'year': '2022', 'journal-title': 'N. Engl. J. Med.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0012', 'doi-asserted-by': 'crossref', 'first-page': '4085', 'DOI': '10.1111/febs.12936', 'article-title': 'From SARS to MERS: crystallographic studies on coronaviral proteases ' 'enable antiviral drug design', 'volume': '281', 'author': 'Hilgenfeld', 'year': '2014', 'journal-title': 'FEBS J.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0013', 'doi-asserted-by': 'crossref', 'first-page': '1610', 'DOI': '10.1001/jama.2019.3087', 'article-title': 'Reporting of multi-arm parallel-group randomized trials: extension of ' 'the CONSORT 2010 statement', 'volume': '321', 'author': 'Juszczak', 'year': '2019', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.phymed.2023.155025_bib0014', 'doi-asserted-by': 'crossref', 'first-page': '681', 'DOI': '10.1007/s11684-020-0801-x', 'article-title': 'The role played by traditional Chinese medicine in preventing and ' 'treating COVID-19 in China', 'volume': '14', 'author': 'Li', 'year': '2020', 'journal-title': 'Front. Med.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0015', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.phymed.2021.153671', 'article-title': 'Combination of Hua Shi Bai Du granule (Q-14) and standard care in the ' 'treatment of patients with coronavirus disease 2019 (COVID-19): a ' 'single-center, open-label, randomized controlled trial', 'volume': '91', 'author': 'Liu', 'year': '2021', 'journal-title': 'Phytomedicine'}, { 'key': '10.1016/j.phymed.2023.155025_bib0016', 'doi-asserted-by': 'crossref', 'first-page': '94', 'DOI': '10.1186/s13020-020-00375-1', 'article-title': 'Reflections on treatment of COVID-19 with traditional Chinese medicine', 'volume': '15', 'author': 'Luo', 'year': '2020', 'journal-title': 'Chin. Med.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0017', 'doi-asserted-by': 'crossref', 'first-page': 'n2713', 'DOI': '10.1136/bmj.n2713', 'article-title': "COVID-19: Pfizer's paxlovid is 89% effective in patients at risk of " 'serious illness, company reports', 'volume': '375', 'author': 'Mahase', 'year': '2021', 'journal-title': 'BMJ'}, { 'key': '10.1016/j.phymed.2023.155025_bib0018', 'doi-asserted-by': 'crossref', 'first-page': '1586', 'DOI': '10.1126/science.abl4784', 'article-title': 'An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the ' 'treatment of COVID-19', 'volume': '374', 'author': 'Owen', 'year': '2021', 'journal-title': 'Science'}, { 'key': '10.1016/j.phymed.2023.155025_bib0019', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.virusres.2020.198057', 'article-title': 'Potential drugs for the treatment of the novel coronavirus pneumonia ' '(COVID-19) in China', 'volume': '286', 'author': 'Pan', 'year': '2020', 'journal-title': 'Virus Res.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0020', 'article-title': 'Traditional Chinese medicine for COVID-19 treatment', 'volume': '155', 'author': 'Ren', 'year': '2020', 'journal-title': 'Pharmacol. Res.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0021', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.phymed.2020.153367', 'article-title': 'Efficacy and safety of Chinese herbal medicine versus ' 'Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: a ' 'non-randomized controlled trial', 'volume': '81', 'author': 'Shi', 'year': '2021', 'journal-title': 'Phytomedicine'}, { 'key': '10.1016/j.phymed.2023.155025_bib0022', 'doi-asserted-by': 'crossref', 'unstructured': 'Su, H., Yao, S., Zhao, W., Li, M., Liu, J., Shang, W., Xie, H., Ke, C., ' 'Gao, M., Yu, K., Liu, H., Shen, J., Tang, W., Zhang, L., Zuo, J., Jiang, ' 'H., Bai, F., Wu, Y., Ye, Y., Xu, Y., 2020. Discovery of baicalin and ' 'baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL ' 'protease in vitro. Biorxiv.', 'DOI': '10.1101/2020.04.13.038687'}, { 'key': '10.1016/j.phymed.2023.155025_bib0023', 'doi-asserted-by': 'crossref', 'first-page': '1345', 'DOI': '10.1080/03639045.2020.1788070', 'article-title': 'Network pharmacology and molecular docking analysis on molecular ' 'targets and mechanisms of Huashi Baidu formula in the treatment of ' 'COVID-19', 'volume': '46', 'author': 'Tao', 'year': '2020', 'journal-title': 'Drug Dev. Ind. Pharm.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0024', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.antiviral.2022.105252', 'article-title': 'Remdesivir, Molnupiravir and Nirmatrelvir remain active against ' 'SARS-CoV-2 Omicron and other variants of concern', 'volume': '198', 'author': 'Vangeel', 'year': '2022', 'journal-title': 'Antiviral Res.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0025', 'first-page': '28', 'article-title': 'Study of molecular mechanism of Huashibaidu decoction on COVID-19 based ' 'on network pharmacology and molecular docking technology', 'volume': '36', 'author': 'Xie', 'year': '2020', 'journal-title': 'Pharmcol. Clin. Chin. Mater. Med.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0026', 'doi-asserted-by': 'crossref', 'first-page': '420', 'DOI': '10.1016/S2213-2600(20)30076-X', 'article-title': 'Pathological findings of COVID-19 associated with acute respiratory ' 'distress syndrome', 'volume': '8', 'author': 'Xu', 'year': '2020', 'journal-title': 'Lancet Respir. Med.'}, { 'key': '10.1016/j.phymed.2023.155025_bib0027', 'first-page': '672', 'article-title': 'Material basis research of anti-COVID-19 Huashibaidu granule gormula', 'volume': '22', 'author': 'Yang', 'year': '2020', 'journal-title': 'Mod. Chin. Med.'}], 'container-title': 'Phytomedicine', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0944711323003860?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0944711323003860?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2023, 8, 26]], 'date-time': '2023-08-26T10:21:02Z', 'timestamp': 1693045262000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0944711323003860'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2023, 11]]}, 'references-count': 27, 'alternative-id': ['S0944711323003860'], 'URL': 'http://dx.doi.org/10.1016/j.phymed.2023.155025', 'relation': {}, 'ISSN': ['0944-7113'], 'subject': [ 'Complementary and alternative medicine', 'Drug Discovery', 'Pharmaceutical Science', 'Pharmacology', 'Molecular Medicine'], 'container-title-short': 'Phytomedicine', 'published': {'date-parts': [[2023, 11]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Efficacy and safety of Huashi Baidu granule plus Nirmatrelvir-Ritonavir ' 'combination therapy in patients with high-risk factors infected with Omicron ' '(B.1.1.529): A multi-arm single-center, open-label, randomized controlled trial', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'Phytomedicine', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.phymed.2023.155025', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, {'value': '© 2023 Published by Elsevier GmbH.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '155025'}